UK Markets closed

Valneva SE American Depositary Shares (VALN)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
33.71-1.64 (-4.64%)
At close: 04:00PM EST
Full screen
Loading interactive chart…
  • Globe Newswire

    Valneva Advances Booster Phase of Cov-Compare Trial of Its Inactivated COVID-19 Vaccine Candidate

    Saint-Herblain (France), January 25, 2022 – Valneva SE, a specialty vaccine company, today announced the start of booster vaccinations in adult participants from its Phase 3 pivotal trial, Cov-Compare. This booster extension is intended to provide both homologous and first heterologous booster data to complement previous positive Phase 1/2 booster results. The data are not intended for the initial regulatory approval process which the Company expects to finalize in the coming weeks. The trial ex

  • Zacks

    Valneva (VALN) Up as COVID-19 Jab Neutralizes Omicron Variant

    Three doses of Valneva's (VALN) inactivated COVID-19 vaccine candidate, VLA2001, neutralizes the Omicron variant of SARS-CoV-2, per data from preliminary lab studies. Shares rally.

  • Globe Newswire

    Valneva’s Inactivated COVID-19 Vaccine Candidate Shown to Neutralize Omicron Variant

    Preliminary laboratory studies demonstrate that three doses of Valneva’s inactivated COVID-19 vaccine candidate VLA2001 induced neutralization of the Omicron variant (B.1.1.529 lineage) 100% of tested serum samples presented neutralizing antibodies against the ancestral virus and Delta variant, and 87% against the Omicron variant Saint Herblain (France), January 19, 2022 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, today announced results from an initial laborat